Intercept Pharmaceuticals, Inc… (NASDAQ:ICPT)

The Top Biopharma Events to Watch in 2020

Posted: January 2, 2020 at 10:25 am

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, AMD, Analog Devices, Applied Materials, Ford, Illumina, Medtronic, Tesla, Wells Fargo and More

Posted: January 2, 2020 at 9:20 am

Stocks turned in a banner 2019, with roughly a 28% gain on the S&P 500, but that's all over now and it's time to look at 2020. The consensus targets ...
Read Full Story »

The Top Biopharma Calendar Events to Watch Going Into 2020

Posted: December 23, 2019 at 11:00 am

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk and scrutiny with regards to their drug candidates passing clinical trials and gaining regulatory approval. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Caesars, Chipotle, Host Hotels, Kellogg, McDonald’s, Shopify, Starbucks, Tiffany and More

Posted: June 25, 2019 at 8:50 am
Last updated: January 6, 2020 3:28 am

The futures traded flat Tuesday morning as investors and traders across Wall Street looked toward the G-20 meeting in Japan and a slew of economic data that is due to ...
Read Full Story »

How Intercept Pharma Shares Could See Blockbuster Drug and See Its Shares Double

Posted: March 5, 2019 at 4:08 pm
Last updated: January 11, 2020 10:29 am

Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) was last seen trading higher after the company's financial reporting. While numbers are always important to see, a more subjective issue is a positive review ...
Read Full Story »

How Intercept Pharma Shatters Expectations With Its Liver Fibrosis Treatment

Posted: February 19, 2019 at 9:50 am
Last updated: January 11, 2020 11:06 am

Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid (OCA) in patients with liver fibrosis due ...
Read Full Story »

Why Gilead’s Pain Is Intercept’s Gain

Posted: February 12, 2019 at 9:50 am
Last updated: January 11, 2020 11:20 am

It's another disappointing day for one of America's top biotech companies. Gilead Sciences Inc.'s (NASDAQ: GILD) selonsertib failed to improve fibrosis in the Phase 3 STELLAR-4 trial, and its shares ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BHP, Cisco, Crown Castle, Gilead, Goldcorp, Take-Two, Varonis, Whiting Petroleum and More

Posted: February 12, 2019 at 8:50 am
Last updated: January 11, 2020 11:20 am

Stocks were indicated higher on Tuesday morning on reports that lawmakers have reached a deal to avert another partial government shutdown. While the Dow Jones industrial average is going to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AON, Conoco, Groupon, JinkoSolar, NextEra, WisdomTree, Xilinx, Yelp and More

Posted: February 4, 2019 at 8:45 am
Last updated: January 11, 2020 11:40 am

Stocks were looking for direction on Monday morning with a light news day. Friday's small market gains put the Dow Jones industrial average up over 2,400 points from its lows ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Posted: January 31, 2019 at 8:45 am
Last updated: January 11, 2020 11:47 am

Stocks surged higher on Wednesday after strong post-earnings reactions from Apple and Boeing, and then Federal Reserve Chair Jerome Powell helped the markets by indicating that the Fed would be ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More

Posted: January 30, 2019 at 8:50 am
Last updated: January 11, 2020 11:51 am

Stocks were indicated to open higher on Wednesday with positive earnings reactions from Apple and Boeing. Earnings season has been off to a mixed start at the start of 2019, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

Posted: November 19, 2018 at 9:00 am
Last updated: January 11, 2020 2:44 pm

  Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Boston Scientific, Etsy, GE, Morgan Stanley, SeaWorld, Skechers, Shopify, Square, Tesla and More

Posted: October 2, 2018 at 8:55 am
Last updated: January 11, 2020 5:02 pm

Stocks were taking a breather on Tuesday, but that is after the Canada trade deal sent the Dow Jones industrials up about 190 points and the S&P 500 up over ...
Read Full Story »

Even More Biopharma Catalysts Coming Through the End of March

Posted: March 17, 2018 at 7:55 am
Last updated: January 12, 2020 2:20 am

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Posted: March 8, 2018 at 11:50 am
Last updated: January 12, 2020 2:38 am

Biotechs companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single word from governing health ...
Read Full Story »